DNA repair gene hOGG1 Codon 326 and XRCC1 Codon 399 polymorphisms and bladder cancer risk in a Japanese population

Japanese Journal of Clinical Oncology

Volumn 38, Issue 3, 2008, Pages 186-191

  Arizono, Katsuyuki ^a   Osada, Yukio ^a   Kuroda, Yoshiki ^a  

^a UNIVERSITY OF MIYAZAKI   (Japan)

Author keywords

Bladder cancer; hOGG1; Polymorphism; XRCC1

Indexed keywords

CYSTEINE; DNA GLYCOSYLTRANSFERASE; HUMAN OXOGUANINE GLYCOSYLASE 1; SERINE; UNCLASSIFIED DRUG; XRCC1 PROTEIN; DNA BINDING PROTEIN; OXOGUANINE GLYCOSYLASE 1, HUMAN; X-RAY REPAIR CROSS COMPLEMENTING PROTEIN 1;

ADULT; AGED; ARTICLE; BLADDER CANCER; CANCER RISK; CODON; CONTROLLED STUDY; DNA REPAIR; EXCISION REPAIR; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; JAPANESE; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK FACTOR; SMOKING; ASIAN; BLADDER TUMOR; CASE CONTROL STUDY; COMORBIDITY; EPIDEMIOLOGY; ETHNOLOGY; GENETICS; JAPAN; MIDDLE AGED; NUCLEOTIDE SEQUENCE; TRANSITIONAL CELL CARCINOMA;

ADULT; AGED; AGED, 80 AND OVER; ASIAN CONTINENTAL ANCESTRY GROUP; BASE SEQUENCE; CARCINOMA, TRANSITIONAL CELL; CASE-CONTROL STUDIES; CAUSALITY; COMORBIDITY; DNA GLYCOSYLASES; DNA-BINDING PROTEINS; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; JAPAN; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; SMOKING; URINARY BLADDER NEOPLASMS;

EID: 40749114768     PISSN: 03682811     EISSN: 14653621     Source Type: Journal    
DOI: 10.1093/jjco/hym176     Document Type: Article

References (40)

1. Silverman DT, Hartge P, Morrison AS, Devesa SS. Epidemiology of bladder cancer. Hematol Oncol Clin North Am 1992;6:1-30.
2. Burch JD, Rohan TE, Howe GR, Risch HA, Hill GB, Steele R, et al. Risk of bladder cancer by source and type of tobacco exposure: A case-control study. Int J Cancer 1989;44:622-8.
3. Vineis P, Talaska G, Malaveille C, Bartsch H, Martone T, Sithisarankul P, et al. DNA adducts in urothelial cells: Relationship with biomarkers of exposure to arylamines and polycyclic aromatic hydrocarbons from tobacco smoke. Int J Cancer 1996;65:314-6.
4. Asami S, Manabe H, Miyake J, Tsurudome Y, Hirano T, Yamaguchi R, et al. Cigarette smoking induces an increase in oxidative DNA damage, 8-hydroxydeoxyguanosine, in a central site of the human lung. Carcinogenesis 1997;18:1763-6.
5. Wiencke JK. DNA adduct burden and tobacco carcinogcnesis. Oncogene 2002;21:7376-91.
6. Loft S, Deng XS, Too J, Wellejus A, Sorensen M, Poulsen HE. Experimental study of oxidative DNA damage. Free Radic Res 1998;29:525-39.
7. Marnett LJ. Oxyradicals and DNA damage. Carcinogenesis 2000;21:361-70.
8. Wilson DM, III, Thompson LH. Life without DNA repair. Proc Natl Acad Sci USA 1997;94:12754-7.
9. Friedberg EC. How nucleotide excision repair protects against cancer. Nat Rev Cancer 2001;1:22-33.
10. Wood RD, Mitchell M, Sgouros J, Lindahl T. Human DNA repair genes. Science 2001;291:1284-9.
11. Kohno T, Shinmura K, Tosaka. M, Tani M, Kim SR, Sugimura H, et al. Genetic polymorphisms and alternative splicing of the hOGG1 gene, that is involved in the repair of 8-hydroxyguanine in damaged DNA. Oncogene 1998;16:3219-25.
12. Yamane A, Kohno, T, Ito K, Sunaga N, Aoki K, Yoshimura K, et al. Differential ability of polymorphic OGG1 proteins to suppress mutagenesis induced by 8-hydroxyguanine in human cell in vivo. Carcinogenesis 2004;25:1689-94.
13. Masson M, Niedergang C, Schreiber V, Muller S, Menissier-de Murcia J, de Murcia G. XRCC1 is specifically associated with poly(ADP-ribose) polymerase and negatively regulates its activity following DNA damage. Mol Cell Biol 1998; 18:3563-71.
14. Kubota Y, Nash RA, Klungland A, Schar P, Barnes DE, Lindahl T. Reconstitution of DNA base excision-repair with purified human proteins: interaction between DNA polymerase beta and the XRCC1 protein. EMBO J 1996; 15:6662-70.
15. Lunn RM, Langlois RG, Hsieh LL, Thompson CL, Bell DA. XRCC1 polymorphisms: Effects on aflatoxin B1-DNA adducts and glycophorin A variant frequency. Cancer Res 1999;59:2557-61
16. Matullo G, Palli D, Peluso M, Guarrera S, Carturan S, Celentano E, et al. XRCC1, XRCC3, XPD gene polymorphisms, smoking and (32)P-DNA adducts in a sample of healthy subjects. Carcinogenesis 2001;22:1437-45.
17. Le Marchand L, Donlon T, Lum-Jones A, Seifried A, Wilkens LR. Association of the hOGG1 Ser326Cys polymorphism with lung cancer risk. Cancer Epidemiol Biomarkers Prev 2002; 11:409-12.
18. Xing DY, Tan W, Song N, Lin DX. Ser326Cys polymorphism in hOGG1 gene and risk of esophageal cancer in a Chinese population. Int J Cancer 2001;95:140-3.
19. Tsukino H, Hanaoka T, Otani T, Iwasaki M, Kobayashi M, Hara M, et al. hOGG1 Ser326Cys polymorphism, interaction with environmental exposures, and gastric cancer risk in Japanese populations. Cancer Sci 2004;95:977-83.
20. Shen M, Hung RJ, Brennan P, Malaveille C, Donato F, Placidi D, et al. Polymorphisms of the DNA repair genes XRCC1, XRCC3, XPD, interaction with environmental exposures, and bladder cancer risk in a case-control study in northern Italy. Cancer Epidemiol Biomarkers Prev 2003;12:1234-40.
21. Divine KK, Gilliland FD, Crowell RE, Stidley CA, Bocklage TJ, Cook DL, et al. The XRCC1 399 glutamine allele is a risk factor for adenocaicinoma of the lung. Mutat Res 2001;461:273-8.
22. Park JY, Lee SY, Jeon HS, Bae NC, Chae SC, Joo S, et al. Polymorphism of the DNA repair gene XRCC1 and risk of primary lungcancer. Cancer Epidemiol Biomarkers Prev 2002;11:23-7.
23. Cho EY, Hildesheim A, Chen CJ, Hsu MM, Chen IH, Mittl BF, et al. Nasopharyngeal carcinoma and genetic polymorphisms of DNA repair enzymes XRCC1 and hOGG1. Cancer Epidemiol Biomarkers Prev 2003;12:1100-4.
24. Bruner SD, Norman DP, Verdine GL. Structural basis for recognition and repair of the endogenous mutagen 8-oxoguanine in DNA. Nature 2000;403:859-66.
25. Shibutani S, Takeshita M, Grollman AP. Insertion of specific bases during DNA synthesis past the oxidation-damaged- base 8-oxodG. Nature 1991;349:431-4.
26. Cheng KC, Cahill DS, Kasai H, Nishimura S, Loeb LA. 8-Hydroxyguanine, an abundant form of oxidative DNA damage, causes G-T and A-C substitutions. J Biol Chem 1992;267:166-72.
27. Shen MR, Jones IM, Mohrenweiser H. Nonconservative amino acid substitution variants exist at polymorphic frequency in DNA repair genes in healthy humans. Cancer Res 1998;58:604-8.
28. Matullo G, Guarrera S, Carturan S, Peluso M, Malaveille C, Davico L, et al. DNA repair gene polymorphisms, bulky DNA adducts in white blood cells and bladder cancer in a case-coutrol study. Int J Cancer 2001;92:562-7.
29. Stern MC, Umbach DM, Lunn RM, Taylor JA. DNA repair gene XRCC3 codon 241 polymorphism, its interaction with smoking and XRCC1 polymorphisms, and bladder cancer risk. Cancer Epidemiol Biomarkers Prev 2002;11:939-43.
30. Kelsey KT, Park S, Nelson HH, Karagas MR. A population-based case-control study of the XRCC1 Arg399GIn polymorphism and susceptibility to bladder cancer. Cancer Epidemiol Biomarkers Prev 2004;13:1337-41.
31. Stern MC, Umbach DM, van Gils CH, Lunn RM, Taylor JA. DNA repair gene XRCC1 polymorphisms, smoking, and bladder cancer risk. Cancer Epidemiol Biomarkers Prev 2001;10:125-31.
32. Sak SC, Barrett JH, Paul AB, Bishop DT, Kiltie AE. DNA repair gene XRCC1 polymorphisms and bladder cancer risk. BMC Genet 2007;8:13.
33. Dizdaroglu M. Chemical determination of free radical-induced damage to DNA. Free Radic Biol Med 1991;10:225-42.
34. Niwa Y, Matsuo K, Ito H, Hiroge K, Tajima K, Nakanishi T, et al. Association of XRCC1 Arg399In and OGG1 Ser326Cys polymorphisms with the risk of cervical cancer in Japanese subjects. Gynecol Oncol 2005;99:43-9.
35. Tsuchiya N, Mishina M, Narita S, Kumazawa T, Inoue T, Horikawa Y, et al. Association of XRCC1 gene polymorphisms with the susceptibility and chromosomal aberration of testicular germ cell tumors. Int J Oncol 2006;28:1217-23.
36. Amos CI, Caporaso NE, Weston A. Host factors in lung cancer risk: A review of interdisciplinary studies. Cancer Epidemiol Biomarkers Prev 1992;1:505-13.
37. Khoury MJ, Adams MJ, Jr, Flanders WD. An epidemiologic approach to ecogenetics. Am J Hum Genet 1988;42:89-95.
38. Wang YC, Chen CY, Chen SK, Chang YY, Lin P. p53 codon 72 polymorphism in Taiwanese lung cancer patients: Association with lung cancer susceptibility and prognosis. Clin Cancer Res 1999;5:129-34.
39. Kim EJ, Jeong P, Quan C, Kim J, Bae SC, Yoon SJ, et al. Genotypes of TNF-alpha, VEGF, hOGG1, GSTM1, and GSTT1: Useful determinants for clinical outcome of bladder cancer. Urology 2005;65:70-5.
40. Patel AV, Calle EE, Pavluck AL, Feigelson HS, Thun MJ, Rodriguez C. A prospective study of XRCC1 (X-ray cross-complementing group 1) polymorphisms and breast cancer risk. Breast Cancer Res 2005;7:R1168-73.